Regulatory interactions between phospholipid synthesis and DNA replication in Caulobacter crescentus.
Several Caulobacter crescentus mutants with lesions in phospholipid biosynthesis have DNA replication phenotypes. A C. crescentus mutant deficient in glycerol 3-phosphate dehydrogenase activity (gpsA) blocks phospholipid synthesis, ceases DNA replication, and loses viability in the absence of a glycerol phosphate supplement. To investigate the interaction between membrane synthesis and DNA replication during a single cell cycle, we moved the gpsA mutation into a synchronizable, but otherwise wild-type, strain. The first effect of withholding supplement was the cessation of synthesis of phosphatidylglycerol, a major component of the C. crescentus membrane. In the absence of glycerol 3-phosphate, DNA replication was initiated in the stalked cell at the correct time in the cell cycle and at the correct site on the chromosome. However, after replication proceeded bidirectionally for a short time, DNA synthesis dropped to a low level. The cell cycle blocked at a distinct middivision stalked cell, and this was followed by cell death. The "glycerol-less" death of the gpsA mutant could be prevented if the cells were treated with novobiocin to prevent the initiation of DNA replication. Our observations suggest that the processivity of C. crescentus replication requires concomitant phospholipid synthesis and that cell death results from incomplete replication of the chromosome.
Department of Developmental Biology, Stanford University School of Medicine, California 94305.
B
B
Loewy
G T
GT
Marczynski
A
A
Dingwall
L
L
Shapiro
D001419:Bacteria / Q000235:genetics / Q000254:growth & development / Q000378:metabolism*; D002453:Cell Cycle; D002876:Chromosomes, Bacterial / Q000502:physiology; D004261:DNA Replication / Q000187:drug effects; D004926:Escherichia coli / Q000235:genetics; D005838:Genotype; D009154:Mutation; D009675:Novobiocin / Q000494:pharmacology; D010743:Phospholipids / Q000096:biosynthesis*
D010743:Phospholipids; D009675:Novobiocin